For US residents only.

My Lung Cancer Is Different; My Treatment Is Too

TAFINLAR + MEKINIST in combination can help treat BRAF V600E metastatic non-small cell lung cancer.

IMPORTANT SAFETY INFORMATION:

What is the most important information I should know about TAFINLAR® (dabrafenib) capsules in combination with MEKINIST® (trametinib) tablets? TAFINLAR and MEKINIST may cause serious side effects, inc...

See More
APPROVED USE:

TAFINLAR, in combination with MEKINIST, is a prescription medication used to treat a type of lung cancer called non-small cell lung cancer (NSCLC) that has spread to other parts of the body (metastatic NSCLC), and that has a certain type of abnormal “BRAF V600E” gene.

 

TAFINL...

See More
Learn more about

TAFINLAR + MEKINIST

If you are starting treatment with TAFINLAR® (dabrafenib) capsules + MEKINIST® (trametinib) tablets for your metastatic (has spread to other parts of the body) NSCLC that has a certain type of abnormal BRAF V600E gene, you can find useful information here about how TAFINLAR + MEKINIST works, its benefits and risks, how to take it, where to get the support, and helpful questions to consider when speaking with health care providers.

Learn More
Learn more about

Non-Small Cell Lung Cancer

There are different types of non-small cell lung cancer (NSCLC), which are classified according to their specific genetic differences. Some NSCLCs have a type of abnormal gene or “gene mutation” called BRAF V600E, which drives cancer cells to grow and multiply. Approximately 2% of patients with metastatic (has spread to other parts of the body) NSCLC have the BRAF V600E gene mutation.

Learn More